AANP honors Sandy Ryan as a 2009 Fellow
CONSHOHOCKEN, Pa. —Take Care Health Systems’ Sandy Ryan, who has been instrumental in the growth and success of the convenient care industry as the industry’s first chief nurse practitioner, has been honored by the American Academy of Nurse Practitioners for her outstanding contributions to health care.
The AANP honored Ryan as a 2009 Fellow during the 24th AANP National Conference in Nashville, Tenn., in June.
Ryan, who has more than 25 years of nursing experience and 16 years of leadership experience in the U.S. Air Force, is an industry trailblazer. She leads Take Care’s clinical forces, including nearly 1,300 board certified nurse practitioners and physician assistants.
“We’re incredibly fortunate to have a leader and healthcare professional of Sandy’s caliber at Take Care Health Systems,” stated Peter Miller, president and CEO of Take Care Health Systems. “Her pioneering spirit and vast array of experience has allowed us to harness the diversified skill-set and patient-centric knowledge of the nurse practitioner community, which in turn enables us to become part of a solution to the healthcare crisis that’s currently facing the United States.”
Added Tine Hansen-Turton, executive director of the Convenient Care Association, “Sandy’s leadership and clinical expertise has been extremely valuable in shaping the convenient care industry as we strive to provide true healthcare access points for millions of [Americans]. The [AANP’s recognition] is well deserved as Sandy continues to be a powerful voice in the healthcare community, creating the framework to allow nurse practitioners to do what they do best—compassionately and holistically treat patients.”
Report: Card-check provision removed from Employee Free Choice Act
NEW YORK The New York Times on Friday reported that the “card-check provision” — which would have required employers to recognize a union as soon as a majority of workers signed cards saying they wanted a union as opposed to a secret-ballot election — has been removed from the Employee Free Choice Act in an effort to secure enough Democratic votes to avoid a filibuster.
It was a polarizing issue — the card-check provision was advocated by union organizations because it would have made it easier to unionize a workforce. In its place, several Senate and labor officials told the New York Times, the revised bill would require shorter unionization campaigns and faster elections — with elections to be held within two work-weeks after 30% of a workforce signed cards favoring unionization.
Gilead enters partnership with Tibotec to develop HIV drug
FOSTER CITY, Calif. Gilead Sciences said it entered a partnership with Tibotec Pharmaceuticals to develop a single daily antiretroviral HIV pill.
The proposed drug would combine Gilead’s Truvada with a drug Tibotec is developing called TMC278, or rilpivirine. Terms were not disclosed, but Gilead said it would take the lead in manufacturing and testing the combined drug, working to get it approved by regulators, and selling it.
Gilead said the product would be the second complete antiretroviral treatment for HIV available in one pill. The first is Gilead’s Atripla, which combines three HIV drugs. The company said the combined pills make treatment simpler for patients.
Tibotec, a unit of Johnson & Johnson, would be responsible for developing rilpivirine as a standalone drug.